Skip to content

Christopher W Fields

6 papers in the library · 33 citations · publishing 2022-2025

Papers

Sort Most recent Most cited

The impact of the serotonergic psychedelic DOI on active vision in freely moving mice.

bioRxiv : the preprint server for biology October 15, 2025 Rolf J. Skyberg, Christopher W Fields, Dylan M. Martins et al. preprint

Psychedelic compounds have the ability to generate altered states of consciousness and profoundly distort perception, often resulting in visual hallucinations. While psychedelics have recently regained attention for their potential cognitive and therapeutic effects, how these drugs affect visual processing to generate visual distortions and hallucinations is not as well characterized....

Psychedelic Therapist Sexual Misconduct and Other Adverse Experiences Among a Sample of Naturalistic Psychedelic Users.

Psychedelic medicine (New Rochelle, N.Y.) March 1, 2025 Daniel J. Kruger, Jacob S. Aday, Christopher W Fields et al. 19 citations

Psychedelic substances have been used for centuries in various cultural and religious contexts, and more recently, in clinical research and therapy. There is a surge of interest in psychedelics, and psychedelic-assisted psychotherapy is becoming increasingly accessible. However, most individuals using psychedelics do so outside of therapeutic contexts. It is important to understand the adverse...

Psychedelic-mediated Reversal of General Anesthesia and Restoration of Brain Dynamics in Rat

bioRxiv Preprint Server January 22, 2025 Emma R. Huels, Nicholas Kolbman, Christopher W Fields et al. 4 citations preprint

Serotonergic psychedelics enhance neurophysiological complexity and the repertoire of brain states, whereas general anesthetics produce opposite effects. Serotonergic psychedelics are also known to increase wakefulness and reduce sleep time in rodents. Therefore, we hypothesized that 2,5-dimethoxy-4-iodopamphetamine (DOI), a serotonergic psychedelic, will reverse general anesthesia and restore...

Slouching towards engagement: interactions between people using psychedelics naturalistically and their healthcare providers

Frontiers in Psychiatry August 4, 2023 Kasey Cox, Cody Weston, Moss Herberholz et al.

Introduction There is substantial public interest in psychedelics as potential treatments for psychiatric conditions. However, most psychedelics are criminalized under federal law in the USA, so it is unclear whether use occurs with clinical support. Our objective was to assess whether naturalistic psychedelic use occurs with clinical support, interactions between those using psychedelics and...

An Assessment of Psychedelic Knowledge Among People Using Psychedelics Naturalistically.

Journal of Psychoactive Drugs 2023 Daniel J. Kruger, Nicolas G. Glynos, Christopher W Fields et al. 10 citations

Identifying gaps and strengths in psychedelic-related knowledge is key to developing effective, evidence-based education to inform appropriate use of and harm reduction practices for psychedelics in the naturalistic use landscape. The current study piloted an assessment instrument with questions on legal status, therapeutic potential, and side effects of psychedelics among people reporting...

Cortical Acetylcholine Levels Correlate With Neurophysiologic Complexity During Subanesthetic Ketamine and Nitrous Oxide Exposure in Rats.

Anesthesia and analgesia June 1, 2022 Michael A. Brito, Duan Li, Christopher W Fields et al.

Neurophysiologic complexity has been shown to decrease during states characterized by a depressed level of consciousness, such as sleep or anesthesia. Conversely, neurophysiologic complexity is increased during exposure to serotonergic psychedelics or subanesthetic doses of dissociative anesthetics. However, the neurochemical substrates underlying changes in neurophysiologic complexity are...